The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death
出版年份 2016 全文链接
标题
The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell Death
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 11, Pages 5960-5970
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2016-01-14
DOI
10.1074/jbc.m115.713545
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Abnormal expression of A20 and its regulated genes in peripheral blood from patients with lymphomas
- (2014) Xu Wang et al. Cancer Cell International
- A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells
- (2013) Dhifaf Sarhan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Akt Inhibitor ISC-4 Synergizes with Cetuximab in 5-FU-Resistant Colon Cancer
- (2013) Joshua E. Allen et al. PLoS One
- The HECTD3 E3 ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8
- (2013) Y Li et al. Cell Death & Disease
- Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways
- (2013) M van Dijk et al. Cell Death & Disease
- Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells
- (2012) Bingfei Dong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A20 Ubiquitin Ligase–Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma
- (2012) Anita C. Bellail et al. Cancer Discovery
- Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
- (2011) E W Duiker et al. BRITISH JOURNAL OF CANCER
- Inhibition of proteasome deubiquitinating activity as a new cancer therapy
- (2011) Pádraig D'Arcy et al. NATURE MEDICINE
- Characterization of Selective Ubiquitin and Ubiquitin-Like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format
- (2010) Xufan Tian et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- The role of deubiquitinating enzymes in apoptosis
- (2010) Suresh Ramakrishna et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- TRAIL receptor signaling and therapeutics
- (2010) Junaid Abdulghani et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact
- (2010) Heath A. Elrod et al. PLoS One
- Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
- (2009) Zhaoyu Jin et al. CELL
- Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8
- (2009) S Häcker et al. ONCOGENE
- Palmitoylation of the TRAIL receptor DR4 confers an efficient TRAIL-induced cell death signalling
- (2008) Aurélie Rossin et al. BIOCHEMICAL JOURNAL
- TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
- (2008) Y. Zhang et al. MOLECULAR CANCER RESEARCH
- Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells
- (2008) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Structure of the A20 OTU domain and mechanistic insights into deubiquitination
- (2007) David Komander et al. BIOCHEMICAL JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started